← All companies

MENS

Jyong Biotech Ltd.

MENS Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.00

-0.23 -10.31%

Key statistics

from XBRL data in SEC filings

Market cap

$152M

Revenue (TTM)

—

Net income (TTM)

-$4.67M

EPS (TTM)

$-0.06

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$1.18M

Total assets

$20.8M

Gross margin

—

52-week range

$1.43 – $67.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

20-F ANNUAL REPORT May 15, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Feb 6, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 9, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jun 20, 2025

Other filings

NT 20-F NOTIFICATION OF LATE FILING Apr 29, 2026 SCHEDULE 13D Apr 24, 2026 3 PRIMARY DOCUMENT Apr 14, 2026 3 PRIMARY DOCUMENT Apr 8, 2026 3 PRIMARY DOCUMENT Apr 1, 2026 3 PRIMARY DOCUMENT Apr 1, 2026 3 PRIMARY DOCUMENT Apr 1, 2026 3 PRIMARY DOCUMENT Apr 1, 2026 3 PRIMARY DOCUMENT Apr 1, 2026 SP 15D2 Jun 30, 2025 424B4 PROSPECTUS Jun 18, 2025 EFFECT Jun 16, 2025 CERT Jun 16, 2025 8-A12B FOR REGISTRATION OF CERTAIN CLASSES Jun 12, 2025 CORRESP Jun 12, 2025 CORRESP Jun 12, 2025 POS AM REGISTRATION STATEMENT Jun 6, 2025 POS AM POST-EFFECTIVE AMENDMENT Apr 23, 2025 EFFECT Mar 31, 2025 CORRESP Mar 28, 2025 CORRESP Mar 28, 2025 FWP FREE WRITING PROSPECTUS Mar 27, 2025 FWP FREE WRITING PROSPECTUS Mar 27, 2025 F-1/A REGISTRATION STATEMENT Mar 11, 2025 FWP FREE WRITING PROSPECTUS Feb 18, 2025 FWP FREE WRITING PROSPECTUS Feb 7, 2025 F-1/A REGISTRATION STATEMENT Feb 6, 2025 F-1/A REGISTRATION STATEMENT Dec 19, 2024 CORRESP Dec 18, 2024 UPLOAD Dec 5, 2024 CORRESP Nov 21, 2024 F-1/A REGISTRATION STATEMENT Nov 21, 2024 UPLOAD Nov 15, 2024 F-1/A REGISTRATION STATEMENT Nov 1, 2024 CORRESP Oct 31, 2024 UPLOAD Oct 24, 2024